Memory Support System Feasibility Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorBruyère Health Research Institute.

About this trial

The purpose of this study is to determining the feasibility of providing the Memory Support System (MSS) to individuals with mild cognitive impairment (MCI) and their partners at a clinic in Ontario, Canada. This will involve a) collecting information from patients referred to the a memory clinic and geriatric day hospital about the patient's interest in and the patient's preferred method to administer the MSS; and b) a cost analysis related to implementation of the MSS. The study will also measure efficacy outcomes of the MSS regarding program adherence as well as to self-reported IADLs, self-efficacy for memory, quality of life, mood, anxiety, and caregiver burden among a sample of individuals with MCI and their care partners

Eligibility criteria

Qualifiers

diagnosis of single or multi-domain MCI

Clinical Dementia Rating global (CDR) score of ≤ 0.5

Montreal Cognitive Assessment score of ≥18

available contact with a care partner ≥ 2 times weekly

Disqualifiers

visual/hearing impairment and/or history of reading or written inability/disability sufficient to interfere with MSS training

concurrent participation in another related clinical trial

Trial design

Treatments tested in this trial

  • Memory Support System

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators

Bruyère Health Research Institute.

Lead sponsor

Ottawa Hospital Research Institute

Collaborator